Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Methotrexate

5

XV.bq Path: Lymphoproliferative disease, endothoracic

1
Last update : 07/06/2016
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
DMARDs (disease-modifying antirheumatic drugs)
5
Pemetrexed
3

Publications

Methotrexate-associated Lymphoproliferative Disorder with Diffuse Ground-Glass Opacities.
American journal of respiratory and critical care medicine 2019 Apr 15;199;1031-1033 2019 Apr 15
A surgical case of methotrexate-associated lymphomatoid granuloma.
General thoracic and cardiovascular surgery 2018 Jul;66;435-438 2018 Jul
Endobronchial Involvement in Methotrexate-associated Lymphoproliferative Disease.
American journal of respiratory and critical care medicine 2016 Jun 01;193;1304-6 2016 Jun 01

Powered by

  • ^
  • Contact
  • Cookies
  • About